The pathogenic spirochete Borrelia burgdorferi has received increasing scientific and public interest since its discovery almost a decade ago. It is the etiologic agent of Lyme disease (Lyme borreliosis), a potentially severe human illness with worldwide endemic foci (11, 23, 45) . The clinical symptoms of Lyme disease vary among individuals and during the course of an infection, ranging from a relatively benign skin rash to severe arthritic, neurologic, and cardiac manifestations (34, 44, (46) (47) (48) . Lyme disease appears to progress to neurologic and dermatologic manifestations more frequently in Europe, whereas arthritis is the more common late manifestation in the United States (43) . The mechanisms underlying the pathologic changes accompanying Lyme disease remain ill defined.
Diagnosis of Lyme disease is not straightforward, primarily because of several characteristics of B. burgdorferi infections. (i) Most of the associated clinical symptoms are not unique to Lyme disease, (ii) strong, specific immunologic responses do not always accompany infection (14, 15, 26) , and (iii) spirochetes generally cannot be directly detected or isolated from infected individuals (45) .
Transmission of Lyme disease usually occurs by way of infected ticks of the Ixodes ricinus complex (10) . Spirochetes are primarily detected in the mid-gut, and systemic infections with spirochetes in the mouthparts and salivary glands are rare (13) . The mechanism by which spirochetes are transmitted following the bite of an infected tick remains debatable (7, 12, 13, 35, 51) . Likewise, it is difficult to envision an efficient means by which ticks in endemic areas become infected, given the low concentration of spirochetes in the blood of the mammals on which they feed.
In order to investigate the transmission and pathogenesis of Lyme disease and to facilitate an accurate diagnosis, our goal has been to develop an assay specific for B. burgdorferi and capable of detecting a single organism. We have previously reported specific and sensitive amplification of B. burgdorferi DNA using the polymerase chain reaction (PCR) (16, 29, 30, 37) and a chromosomally encoded target sequence (36) . As described, the PCR assay was species specific and detected 17 of 18 strains of B. burgdorferi * Corresponding author.
tested. It was unclear whether the German isolate that was not detected by this assay was exceptional or representative of a class of somewhat more divergent European strains. The sensitivity of the PCR assay extended down to a few copies of B. burgdorferi DNA, even in the presence of a large excess of eukaryotic DNA. Hence, it appeared to be applicable to the analysis of infected tissues. However, hybridization with a probe homologous to the target sequence was needed to identify the specific amplification product, because multiple nonspecific fragments were generated from eukaryotic DNA.
In this study we refined the specificity of the PCR assay for B. burgdorferi. We successfully extended the reactivity of the assay to all strains of B. burgdorferi tested to date, including those of European and Asian origin. Likewise, we eliminated the nonspecific amplification of eukaryotic DNA and hence the need for the more laborious hybridization step. These modifications should substantially enhance the utility of this assay in both basic research and diagnostic applications.
Perhaps equally important, though, was the "typing" of B. burgdorferi strains by their differential primer reactivities in this PCR assay. All North American strains tested to date fall into a single reactivity group, whereas European strains fall into two groups, one of which is indistinguishable from the North American type. It is tantalizing to speculate that these two groups may be reflected clinically in the arthritic versus neurologic spectra of Lyme disease as seen in the United States and Europe.
MATERIALS AND METHODS
Borrelia strains and cultivation. Borrelia cultures were maintained in BSKII medium (3) at 35°C and passaged twice a week. The biological and geographical origins of strains are described in Table 1 (17) . Three positive colonies were identified, and recombinant plasmids were prepared by alkaline lysis (28) . Restriction digests with HindIl and EcoRI demonstrated identical inserts of approximately 1.6 kb in all three clones.
Sequencing. The complete sequence of the G2 insert (clone designated G2-48) was determined by the dideoxy-chain termination technique (38) NMWL filter unit; Millipore Corp., Bedford, Mass.) before both the single-strand PCR amplification and the sequencing. PCR. Oligonucleotides were synthesized with a SAM One DNA Synthesizer (Biosearch, San Raphael, Calif.). Taq polymerase and PCR reagents (Perkin Elmer-Cetus, Norwalk, Conn.) were used with an automated DNA thermal cycler (Perkin Elmer-Cetus). A total of 30 pmol of each primer was used per 100-pA reaction. Unless otherwise specified, 100 ng of total genomic DNA was amplified for 25 cycles under the following conditions: 94°C, 1 min; 37°C, 30 s; 60°C, 1 min. A total of 10 ,ul per reaction was analyzed on 1.5% agarose-0.5 x TBE gels under standard electrophoresis conditions (28) . PCR amplification of the osp locus was done under the following conditions: 94°C, 1 min; 37°C, 30 s; 60°C, 3 min. Samples were analyzed on 0.8% agarose-0.5x TBE gels. Nested PCR conditions are specified in the legend to Fig. 4 . The nucleotide sequences of the PCR primers are shown in Fig. 1 .
Nucleotide sequence accession numbers. The GenBank numbers for the nucleotide sequences reported here are M58429 (for strain 20004), M58430 (for B. hermsii), M58431 (for G2), M58432 (for HB19), and M58433 (for B31).
RESULTS
PCR target sequence comparison among North American and European B. burgdorferi isolates. The previously described B. burgdorferi PCR target sequence (36) was derived from the prototype North American tick isolate B31 (11) . A 1.6-kb BglII fragment containing the homologous segment of DNA from the nonreactive European isolate G2 (from human cerebrospinal fluid [20] ) was cloned and sequenced to facilitate the design of more broadly reactive PCR primers. The published B31 sequence corresponds to nucleotides 139 to 520 of the cloned G2 fragment (Fig. 2) . Strains B31 and G2 exhibited approximately 90% nucleotide identity over this region. The positions of the original PCR primers (nucleotides 147 to 164 and 500 to 520, previously designated A and C, respectively) are underlined on the B31 sequence. The lack of reactivity of these primers with G2 DNA is easily understood, given the degree of mismatch between the B31 and G2 sequences at these positions. Fig. 2 ) showed no amplification of B. burgdorferi DNA (Fig. 3d) . Primers derived from sequences unique to B31 (nucleotides 147 to 164 and 500 to 520; underlined on the B31 sequence, Fig. 2 ) or G2 (nucleotides 139 to 158 and 476 to 495; underlined on the G2 sequence, Fig. 2 ) were specific for DNA from the respective B. burgdorferi strain (Fig. 3a and b) .
PCR amplification of genomic DNA from 31 
burgdorferi isolates demonstrated that the primers to sequences conserved between B31 and G2 reacted with all strains tested (PCR primer set c, Table 1 ). These included 21 North American isolates, 9 European isolates, and 1 Japanese isolate from ticks (six species), rodents (three species), and humans (three different tissues ( Fig. 3c) , other members of the genus Borrelia, or Treponema pallidum (data not shown).
PCR amplification of B. burgdorferi with primers to sequences unique to either B31 or G2 (Fig. 2) subdivided B. burgdorferi isolates into two groups. B31 primers detected all North American and some European isolates (PCR primer set a, Table 1 ). G2 primers exhibited a "mirrorimage" pattern of reactivity (PCR primer set b, Table 1 ); that is, previously nonreactive European and Asian isolates were amplified, whereas none of the North American nor the two previously detected European strains (20004 and IP2) were amplified. Uncloned strain IP2 showed a faint signal after 10 additional cycles of amplification with G2 primers. However, cloned lines derived from IP2 reacted with only the B31 primers. This presumably reflects a mixture of both "types" of B. burgdorferi in the original uncloned isolate, with the B31 type predominating, since the nature of the primers would preclude the binding of a single DNA sequence to both sets. Neither the B31 nor G2 primers were reactive with B. hermsii ( Fig. 3a and b, respectively) , other members of the genus Borrelia, or T. pallidum (36; data not shown).
PCR amplification with primers flanking the plasmidencoded osp operon, using sequences from the B31 strain (nucleotides 1 to 20 and 1896 to 1915 [8] ), similarly did not amplify G2 DNA (Fig. 3e) . Amplification of the same panel of 31 strains with these primers gave a reactivity pattern identical to that of the B31-type primers for the chromosomal target locus (PCR primer set a, Table 1 ). That is, they reacted with all North American strains and European strains 20004 and IP2. Hence, PCR typing with both chromosomal and plasmid-derived target sequences subdivides B. burgdorferi strains into the same two groups.
B. herinsii-specific PCR primers. Amplification of Borrelia DNA with primers derived from B. hermsii sequences that were divergent from B. burgdorferi (nucleotides 140 to 163 and 396 to 416; underlined on the B. hermsii sequence in Fig.  2 ) demonstrated specificity for the North American relapsing fever spirochetes B. hermsii, B. parkeri, and B. turicatae (Fig. 4) . No reactivity was detected with B. coriaceae, B.
crocidurae, or B. anserina, the agents of epizootic bovine abortion (putative), Mediterranean relapsing fever, and avian spirochetosis, respectively (22, 24) . Likewise, these primers did not react with B31 or G2 DNA (Fig. 4) or any of the remaining 29 B. burgdorferi isolates tested (data not shown).
PCR amplification using "nested" primers. Although PCR amplification of bacterial DNA with most primers generates only a single specific fragment, extensive amplification of highly complex eukaryotic DNA frequently results in multiple nonspecific products. As shown in Fig. 2 . The total number of cycles for which a sample was amplified is indicated. Samples analyzed in lanes 6 and 8 were initially amplified for 30 (Fig. 5,  lanes 3 and 10) . However, after 45 cycles of amplification in the presence of 200 ng of eukaryotic (mouse) DNA, multiple fragments were generated and no difference was seen between eukaryotic DNA alone or with 0.1 pg ofB. burgdorferi DNA (Fig. 5, lanes 5 and 7, respectively) . As demonstrated previously (36), a hybridization step with an internal B. burgdorferi probe is necessary in such instances to demonstrate a specific B. burgdorferi fragment. This step can be eliminated, however, with two sequential PCRs by using nested primers (29) , as follows.
Thirty cycles of PCR amplification were performed with the external pair of primers (set a); 5% of this reaction was placed in a new reaction mixture containing only the internal primers (set f), and this reaction was amplified 15 additional cycles. As shown in Fig. 5 , when such a protocol was followed with 0.1 pg of B. burgdorferi DNA in the presence of 200 ng of eukaryotic DNA, only a single fragment of the appropriate size was generated (Fig. 5, lane 6 ; compare with lane 9 or 10). Significantly, when the same procedure was followed with 200 ng of eukaryotic DNA alone without any B. burgdorferi DNA, there was no amplified product (Fig. 5,  lane 8) . Hence, this protocol resulted in the specific amplification of only the B. burgdorferi fragment, and nonspecific products of eukaryotic DNA were eliminated. Hybridization with an internal probe is no longer necessary since the B. burgdorferi fragment can be visualized directly. Similar results were obtained with other sets of nested primers and with human and tick (eukaryotic) DNAs (data not shown). (27, 31, 32 (33) exaggerate apparent genomic differences among borreliae, both within and between species. The nucleotide sequence of the homologous segment of DNA from B. hermsii also allowed us to design B. hermsiispecific primers. This has particular relevance in regions such as the northwestern United States that are endemic for relapsing fever but in which a competent tick vector for B. burgdorferi has not been described. Speculation has arisen that presumed cases of Lyme disease in these regions may actually represent atypical, chronic B. hermsii infections (25) . Proper identification of spirochetes in field specimens (or clinical samples) would contribute to our understanding of the epidemiology and transmission of Lyme disease and would perhaps indicate a new manifestation of relapsing fever. The B. hermsii PCR primers detected two additional agents of relapsing fever, B. turicatae and B. parkeri. These spirochetes were initially classified as different species of Borrelia by the criterion that each had a unique tick vector, but more recent estimates of genetic relatedness indicate that they probably make up a single species (21) . The B. hermsii-specific primers did not cross-react with any other Borrelia species tested, including B. crocidurae, a distinct species of spirochete that causes Mediterranean relapsing fever (18) .
DISCUSSION
In this report we presented data that provide the basis for a broadly reactive, B. burgdorferi-specific PCR assay. The applicability of this assay to the detection of B. burgdorferi in infected mammalian and arthropod tissues is apparent and is being undertaken. We also demonstrated that all B. burgdorferi isolates tested to date can be divided into two groups. The relationship between this typing of B. burgdorferi and the clinical manifestations of disease remains to be explored.
